Journal of Peking University(Health Sciences) ›› 2016, Vol. 48 ›› Issue (2): 356-360. doi: 10.3969/j.issn.1671-167X.2016.02.033
• Article • Previous Articles Next Articles
CHEN Zhi-qiang△, WANG Ying, MI Xian-jun, CHEN Ang, HUANG Hua-yong, ZHONG Shou-jun, DENG Wen-tong, LIU Chao-fan, XU Xiu-mei, DAI Xin-zhen
CLC Number:
[1] | 挺 李. [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 197-200. |
[2] | 桥 周. [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 201-209. |
[3] | Yun-yi XU,Zheng-zheng SU,Lin-mao ZHENG,Meng-ni ZHANG,Jun-ya TAN,Ya-lan YANG,Meng-xin ZHANG,Miao XU,Ni CHEN,Xue-qin CHEN,Qiao ZHOU. Read-through circular RNA rt-circ-HS promotes hypoxia inducible factor 1α expression and renal carcinoma cell proliferation, migration and invasiveness [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 217-227. |
[4] | Wei WANG,Xin LI,Ping LIU,Ying DONG. Clinical value of fluorescence in situ hybridization with MDM2 and DDIT3 probe in diagnosis of liposarcoma [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 228-233. |
[5] | Dong LI,Ji-ting DI,Yan XIONG. Consistency comparison of programmed cell death 1-ligand 1 in different immuno-histochemical staining methods [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 339-342. |
[6] | Yan XIONG,Bo ZHANG,Li-gong NIE,Shi-kai WU,Hu ZHAO,Dong LI,Ji-ting DI. Thoracic SMARCA4-deficient undifferentiated tumor-pathological diagnosis and combined immune checkpoint inhibitor treatment [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 351-356. |
|